See our newest press release:
Potential drug for pancreatic cancer now being tested in animals
Existing cancer therapies are geared toward massacring tumor cells, but Johns Hopkins researchers propose a different strategy: subtly hardening cancer cells to prevent them from invading new areas of the body. They devised a way of screening compounds for the desired effect and have identified a compound that shows promise in fighting pancreatic cancer. Their study appears this week in the early edition of the Proceedings of the National Academy of Sciences.
Please click here to see the rest of the story.
If you are interested in helping support our research enterprise or our Summer Academic Research Experience (SARE) program for disadvantaged Baltimore youth, please contact Doug (firstname.lastname@example.org) or Geminesse Johnson, Associate Director of Development, Institute for Basic Biomedical Sciences (email@example.com).